SCHEMBL9169293

SCHEMBL9169293

CC(C)(CSCc1ccccc1)C(=O)N[C@@H](CSCc1ccccc1)C(=O)NCCCCN

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TLR2 O60603 1/20 0.47
▸ CHRNA1 P02708 4/20 0.45
▸ CHRNG P07510 4/20 0.45
▸ CHRNB1 P11230 4/20 0.45
▸ CHRND Q07001 4/20 0.45
▸ CHRNB2 P17787 2/20 0.45
▸ CHRNB4 P30926 2/20 0.45
▸ CHRNA3 P32297 2/20 0.45
▸ CHRNA4 P43681 2/20 0.45
▸ GRIA1 P42261 2/20 0.45
▸ MMP1 P03956 1/20 0.44
▸ MMP3 P08254 1/20 0.44
▸ MMP9 P14780 1/20 0.44
▸ ACE P12821 1/20 0.43
▸ CPB1 P15086 1/20 0.42
▸ CPB2 Q96IY4 1/20 0.42
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9164248 0.99 TLR2 (0.48) TLR2CHRNA1CHRNGCHRNB1CHRND
SCHEMBL9166218 0.99 TLR2 (0.48) TLR2CHRNA1CHRNGCHRNB1CHRND
SCHEMBL9174024 0.97 CHRNB2 (0.45) TLR2CHRNA1CHRNGCHRNB1CHRND
SCHEMBL9170928 0.94 ACE (0.46) GRIA1ACEPPARGPPARA
SCHEMBL9169284 0.90 ACE (0.43) GRIA1ACEPPARGPPARA
SCHEMBL9172971 0.86 ACE (0.49) MMP1MMP3MMP9ACEPPARG
SCHEMBL9167736 0.84 ACE (0.46) ACEPPARGPPARA
SCHEMBL9170095 0.84 GLO1 (0.49) ACEPPARGPPARA
SCHEMBL9169296 0.82 PPARG (0.41) MMP1MMP3MMP9ACEPPARG
SCHEMBL9166230 0.82 MMP2 (0.41) MMP1MMP3MMP9ACEPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0455833-B1 AMINO ACID DERIVATIVE SANTEN PHARMACEUTICAL CO LTD (JP) 1995-04-19 — — EP disclosed
US-5214181-A Immunodeficiency and autoimmune disease treatment SANTEN PHARMACEUTICAL CO., LTD. (JP) 1993-05-25 — — US disclosed
Send feedback